Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastatic colorectal cancer – Results from a prospective cohort study.

Marschner, N., Arnold, D., Engel, E., Hutzschenreuter, U., Rauh, J., Freier, W., Hartmann, H., Frank, M., Jänicke, M., 2015.

Clinical Epidemiology 7, 295–303. doi:10.2147/CLEP.S73857

Studie: TKK; Indikation: Kolorektalkarzinom; Jahr: 2015; Veranstaltung: -; Journal: Journal of Clinical Epidemiology

iOMEDICO AG
Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com